Shelhamer Mehdi, Wesson Paul D, Solari Ian L, Jensen Deanna L, Steele William Alex, Dimitrov Vihren G, Kelly John Daniel, Aziz Shazia, Gutierrez Victor Perez, Vittinghoff Eric, Chung Kevin K, Menon Vidya P, Ambris Herman A, Baxi Sanjiv M
NYC Health and Hospitals Lincoln.
University of California San Francisco.
Res Sq. 2020 Aug 17:rs.3.rs-56281. doi: 10.21203/rs.3.rs-56281/v1.
Coronavirus disease 2019 (COVID-19) can lead to acute respiratory distress syndrome (ARDS) but it is unknown whether prone positioning improves outcomes in mechanically ventilated patients with moderate to severe ARDS due to COVID-19.
A cohort study at a New York City hospital at the peak of the early pandemic in the United States, under crisis conditions. The aim was to determine the benefit of prone positioning in mechanically ventilated patients with ARDS due to COVID-19. The primary outcome was in-hospital death. Secondary outcomes included changes in physiologic parameters. Fine-Gray competing risks models with stabilized inverse probability treatment weighting (sIPTW) were used to determine the effect of prone positioning on outcomes. In addition, linear mixed effects models (LMM) were used to assess changes in physiology with prone positioning.
Out of 335 participants who were intubated and mechanically ventilated, 62 underwent prone positioning, 199 met prone positioning criteria and served as controls and 74 were excluded. The intervention and control groups were similar at baseline. In multivariate-adjusted competing risks models with sIPTW, prone positioning was significantly associated with reduced mortality (SHR 0.61, 95% CI 0.46-0.80, < 0.005). Using LMM to evaluate the impact of positioning maneuvers on physiological parameters, the oxygenation-saturation index was significantly improved during days 1-3 ( < 0.01) whereas oxygenation-saturation index (OSI), oxygenation-index (OI) and arterial oxygen partial pressure to fractional inspired oxygen (P O :FiO ) were significantly improved during days 4-7 ( < 0.05 for all).
Prone positioning in patients with moderate to severe ARDS due to COVID-19 is associated with reduced mortality and improved physiologic parameters. One in-hospital death could be averted for every eight patients treated. Replicating results and scaling the intervention are important, but prone positioning may represented an additional therapeutic option in patients with ARDS due to COVID-19.
2019冠状病毒病(COVID-19)可导致急性呼吸窘迫综合征(ARDS),但对于因COVID-19导致的中重度ARDS机械通气患者,俯卧位通气是否能改善预后尚不清楚。
在美国疫情早期高峰时,纽约市一家医院在危机状况下进行的一项队列研究。目的是确定俯卧位通气对因COVID-19导致ARDS的机械通气患者的益处。主要结局是院内死亡。次要结局包括生理参数的变化。采用带有稳定逆概率治疗权重(sIPTW)的Fine-Gray竞争风险模型来确定俯卧位通气对结局的影响。此外,使用线性混合效应模型(LMM)来评估俯卧位通气时生理状态的变化。
在335例接受气管插管和机械通气的参与者中,62例接受了俯卧位通气,199例符合俯卧位通气标准并作为对照组,74例被排除。干预组和对照组在基线时相似。在采用sIPTW的多变量调整竞争风险模型中,俯卧位通气与死亡率降低显著相关(SHR 0.61,95%CI 0.46 - 0.80,<0.005)。使用LMM评估体位改变对生理参数的影响,在第1 - 3天氧合饱和度指数显著改善(<0.01),而在第4 - 7天氧合饱和度指数(OSI)、氧合指数(OI)和动脉血氧分压与吸入氧分数之比(P O :FiO )均显著改善(均<0.05)。
因COVID-19导致的中重度ARDS患者采用俯卧位通气与死亡率降低及生理参数改善相关。每治疗8例患者可避免1例院内死亡。重复研究结果并扩大干预范围很重要,但俯卧位通气可能是因COVID-19导致ARDS患者的一种额外治疗选择。